Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

88.50
Delayed Data
As of Sep 29
 -0.75 / -0.84%
Today’s Change
80.53
Today|||52-Week Range
117.77
-14.48%
Year-to-Date

Today’s Trading

Previous close89.25
Today’s open89.84
Day’s range88.34 - 89.94
Volume43,728
Average volume (3 months)1,250,988
Market cap$16.7B
Data as of 4:00pm ET, 09/29/2023

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+49.68%
Earnings growth (next 5 years)+1.75%
Revenue growth (last year)+10.91%
P/E ratio170.2
Price/Sales9.55
Price/Book3.58

Competitors

----
EXASExact Sciences Corp-0.98-1.42%
ILMNIllumina Inc+4.92+3.72%
NBIXNeurocrine Bioscienc...-2.69-2.34%
Data as of 4:00pm ET, 09/29/2023

Financials

Next reporting dateOctober 25, 2023
EPS forecast (this quarter)$0.23
Annual revenue (last year)$2.0B
Annual profit (last year)$141.6M
Net profit margin6.91%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Rafael, California

Forecasts